The Week Ahead In Biotech: J&J Earnings Kickstarts Pharma Earnings, More IPOs In The Pipeline

Biotech stocks advanced along with the market in the past week, though the news flow was light. Antibody treatment for COVID-19 took the spotlight, with both Eli Lilly And Co and Regeneron Pharmaceuticals Inc requesting emergency use authorizations.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.